Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 35

Results For "pandemic"

698 News Found

Johnson & Johnson India launches ‘Be The Change For TB’ initiative
Public Health | March 24, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India


MedisimVR raises Rs 3.5 cr. in Pre-Series A round led by Inflection Point Ventures
Startup | March 24, 2022

MedisimVR raises Rs 3.5 cr. in Pre-Series A round led by Inflection Point Ventures

MedisimVR is a VR based medical education platform for doctors, nurses & allied health professionals. It aims to make comprehensive Virtual Reality medical simulation more accessible and affordable


Lonza appoints Christian Seufert as President of CHI Division
People | March 23, 2022

Lonza appoints Christian Seufert as President of CHI Division

Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


Mandaviya launches BRICS vaccine R&D centre
Policy | March 22, 2022

Mandaviya launches BRICS vaccine R&D centre

The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines


Akston Biosciences and Biolexis partner to develop second-gen COVID-19 vaccine
News | March 19, 2022

Akston Biosciences and Biolexis partner to develop second-gen COVID-19 vaccine

Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships


Tata Elxsi has unveiled TEngage, a digital health platform
Digitisation | March 19, 2022

Tata Elxsi has unveiled TEngage, a digital health platform

In contrast to the digital health solutions in the market, TEngage is cloud-based, fully customizable and allows hospitals to implement modules with just the required features, keeping the deployment and operational cost in check


Thirty five generic manufacturers sign agreements with MPP for Paxlovid
News | March 18, 2022

Thirty five generic manufacturers sign agreements with MPP for Paxlovid

The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris


BASF to double production capacity of dispersion at its site in Indonesia
News | March 17, 2022

BASF to double production capacity of dispersion at its site in Indonesia

The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry


Zen hospital opens dedicated cancer facility
Hospitals | March 16, 2022

Zen hospital opens dedicated cancer facility

According to the Indian Council of Medical Research (ICMR), there will be an estimated 12 % rise in cancer cases in India in the next five years